
Last week the King and DeForest labs celebrated a successful defense from Dr. Cyrus Haas 🥳🍾 We're so proud of everything you've accomplished and can't wait to see what you do next!

News from the King Lab @UW. Part of @UWproteindesign and @UWBiochemistry. Some assembly required.

Last week the King and DeForest labs celebrated a successful defense from Dr. Cyrus Haas 🥳🍾 We're so proud of everything you've accomplished and can't wait to see what you do next!

I've seen a lot of beautiful assemblies under the microscope - stoked to put this together and show some of the design it's enabled! More quasisymmetry to come
Excited to share our latest @biorxivpreprint, led by Dr. Chelsea Fries @assemblingfries 🥳 Here, we establish multistate interface design as a strategy for engineering protein assemblies that break symmetry and switch between distinct geometries. bit.ly/47ZqHNK

Excited to share our latest @biorxivpreprint, led by Dr. Chelsea Fries @assemblingfries 🥳 Here, we establish multistate interface design as a strategy for engineering protein assemblies that break symmetry and switch between distinct geometries. bit.ly/47ZqHNK

This is what a communal brain—a central tenet of the IPD approach—looks like in action. 🧠 We're thrilled to present RFD4-Proteina, co-developed with @NVIDIAHealth! Can't wait to see what you build: rfd4-proteina.org/
🧬 Design proteins faster and send fewer, better candidates to the lab. Introducing RFD4-Proteina, a new NVIDIA BioNeMo open model co-developed with @UWproteindesign. ▫️Fast: 13× faster generation than RFdiffusion3 at 200 residues ▫️ Smart: state-of-the-art across 12+ protein design tasks ▫️ Programmable: set your design inputs and use test-time compute on harder problems Start with our binder-design tutorial nvda.ws/3VK9Uvr

most protein design focuses on using the 20 amino acids for protein function. in biology, post-translational modifications such as glycosylations are essential to function. we program protein function through glycosylation👇
🚨 pre-print alert 🚨 Glycosylation has remained outside the reach of biomolecular design, but with new all-atom methods we are now able to control the types of glycans displayed on our de novo proteins. In our newest @biorxivpreprint, we present multiple structurally-encoded oligomannose-type glycoproteins, establishing glycans as a designable parameter! bit.ly/4s2qK4M

These glycoproteins engage immune lectins and pathogenic bacterial adhesins through their #glycans, showing that we can now design functional glycoproteins.

🚨 pre-print alert 🚨 Glycosylation has remained outside the reach of biomolecular design, but with new all-atom methods we are now able to control the types of glycans displayed on our de novo proteins. In our newest @biorxivpreprint, we present multiple structurally-encoded oligomannose-type glycoproteins, establishing glycans as a designable parameter! bit.ly/4s2qK4M

🚨 new paper alert 🚨 Here we apply our protein nanoparticle vaccine platform toward a bacterial indication: uropathogenic E. coli, the primary causative agent of UTIs: bit.ly/4waDqaM

Last week, Grace Hendricks successfully defended her dissertation and earned her PhD!

Excited to share our new preprint: “Computational design of membrane fusion proteins” Huge thanks to all collaborators, co-authors, @KingLabIPD, and everyone at @UWproteindesign who contributed to this work. Preprint: biorxiv.org/content/10.64898…

.@KingLabIPD ski on a beautiful spring day at Crystal! I love my coworkers 💜💛

A team presents vaccines for H5 clade #influenza based on a stabilized H5 hemagglutinin stem, which improves the breadth and depth of antibody responses and protects against #H5N1 challenge in immunized mice. @KingLabIPD @anniedosey @UWBiochemistry scim.ag/4reeKei

🚨 new paper alert 🚨 Here we demonstrate increased anti-RBS neutralizing responses elicited by stabilized influenza H5 immunogens: bit.ly/4u8UxJl

Happy New Year! We are delighted to share with you our newest @biorxivpreprint, in which we describe the de novo design of protein nanoparticles with structures tailored to specific applications. Long a dream, it is now reality! biorxiv.org/content/10.64898…

Yesterday Dane Zambrano successfully defended her thesis on hybrid lipid-protein nanoparticles! Excellent work Dr. Dane!!

🚨new paper alert🚨 Here, we show how recently developed ML tools can be leveraged to design self-assembling protein nanoparticle immunogens in the absence of experimentally determined structures of the oligomeric building blocks. Read more @PNASNews: doi.org/10.1073/pnas.2409566…